Cargando…

CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells

Cytochrome P4501B1 (CYP1B1) is elevated in breast cancer. Studies indicate a relationship between CYP1B1 and aggressive cancer phenotypes. Here, we report on in vitro studies in triple-negative breast cancer cell lines, where knockdown (KD) of CYP1B1 was used to determine the influence of its expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hollis, Paul R., Mobley, Robert J., Bhuju, Jyoti, Abell, Amy N., Sutter, Carrie Hayes, Sutter, Thomas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456208/ https://www.ncbi.nlm.nih.gov/pubmed/36077068 http://dx.doi.org/10.3390/ijms23179670

Ejemplares similares

Cutaneous Effects of In Utero and Lactational Exposure of C57BL/6J Mice to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
por: Bhuju, Jyoti, et al.
Publicado: (2021)

HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells
por: Lyu, Hui, et al.
Publicado: (2023)

Contributions of Nitric Oxide to AHR-Ligand-Mediated Keratinocyte Differentiation
por: Sutter, Carrie Hayes, et al.
Publicado: (2020)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4
por: Lin, Xinjian, et al.
Publicado: (2013)

Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells
por: Levine, Fayola, et al.
Publicado: (2021)

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model
por: Matossian, Margarite D., et al.
Publicado: (2018)

Detection of Increased Expression of Claudin-1 in Triple-Negative Breast Cancer: Analysis and Clinical-Pathological Correlation
por: Ouban, Abderrahman, et al.
Publicado: (2023)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021)

DCST1-AS1 Promotes TGF-β-Induced Epithelial–Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1
por: Tang, Li, et al.
Publicado: (2020)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Caveolin 1 is Associated with Upregulated Claudin 2 in Necrotizing Enterocolitis
por: Ares, Guillermo, et al.
Publicado: (2019)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple‐negative breast cancer
por: Zhang, Danfang, et al.
Publicado: (2020)

Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo
por: Wible, Ryan S., et al.
Publicado: (2018)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
por: Agnello, Lisa, et al.
Publicado: (2023)

High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method
por: Naimi, Azar, et al.
Publicado: (2022)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
por: Gowrikumar, Saiprasad, et al.
Publicado: (2021)

Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactions
por: Schlingmann, Barbara, et al.
Publicado: (2016)

Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients
por: Chen, Yan, et al.
Publicado: (2021)

All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4
por: Shousha, Sami, et al.
Publicado: (2019)

NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus
por: Wible, Ryan S, et al.
Publicado: (2018)

Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance
por: Li, Ying, et al.
Publicado: (2019)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
por: Lin, Yueh-Te, et al.
Publicado: (2022)

Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy
por: Gowrikumar, Saiprasad, et al.
Publicado: (2019)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
por: Liu, Weiguang, et al.
Publicado: (2019)

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
por: Si, Wentao, et al.
Publicado: (2022)

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer
por: KARABULUT, MEHMET, et al.
Publicado: (2015)

Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis
por: Georges, Rania, et al.
Publicado: (2012)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
por: Liu, Weiguang, et al.
Publicado: (2019)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

The claudins
por: Lal-Nag, Madhu, et al.
Publicado: (2009)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
por: He, Lin, et al.
Publicado: (2021)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

DOCK1 Regulates Growth and Motility through the RRP1B-Claudin-1 Pathway in Claudin-Low Breast Cancer Cells
por: Chiang, Shih-Kai, et al.
Publicado: (2019)

Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells
por: Zhao, Xianqi, et al.
Publicado: (2015)

Claudin 1 in Breast Tumorigenesis: Revelation of a Possible Novel “Claudin High” Subset of Breast Cancers
por: Myal, Yvonne, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bp9tt11jd7m2gc8qhnk18h0njt